Atrial natriuretic peptide inhibits neurohypophysial hormones' release in the rat (in vitro and in vivo studies).
Intracerebroventricular hANP (50 nmol) inhibits release of vasopressin and oxytocin following dehydration as well as after haemorrhage. 10 nmol/L hANP markedly inhibits vasopressin and oxytocin release in vitro from the neurointermediate lobes both under basal condition as well as during stimulation with excess (56 mM) potassium. It is suggested that ANP may serve as a modulator of vasopressin and oxytocin release. The respective processes are localized, at least in part, at the neurohypophysial level.
Lewandowska
A
A
Department of Pathophysiology, School of Medicine, Lódź, Poland.
Szyburska
I
I
Guzek
J W
JW
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D003681:Dehydration / Q000503:physiopathology; D005268:Femoral Vein; D006470:Hemorrhage / Q000503:physiopathology; D007276:Injections, Intraventricular; D008297:Male; D010121:Oxytocin / Q000378:metabolism; D010904:Pituitary Gland, Posterior / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D010909:Pituitary Hormones, Posterior / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014667:Vasopressins / Q000378:metabolism
D010909:Pituitary Hormones, Posterior; D014667:Vasopressins; D010121:Oxytocin; D009320:Atrial Natriuretic Factor; D011188:Potassium